During biotech’s biggest week of the year, CG Life Managing Partner Erik Clausen recently conducted a series of interviews on YouTube with presenting biotech CEOs. In this series of brief interviews, discussion topics ranged from rare diseases and drug pricing policies to evidence-based strategies guiding investment and how health companies can access seed capital.